Jianxiang Wang

Title: Innovations of Jianxiang Wang

Introduction

Jianxiang Wang is a notable inventor based in Tianjin, China. He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptors and gene discovery. With a total of 2 patents, his work has the potential to impact therapeutic approaches in medicine.

Latest Patents

Wang's latest patents include a CD19-targeted chimeric antigen receptor and its applications. This invention comprises an amino acid sequence and a nucleic acid encoding the chimeric antigen receptor. It also involves a vector that includes the nucleic acid, an immune effector cell, and methods for preparing the immune effector cell. Additionally, he has patented the cloning of the human nuclear receptor co-repressor gene. This invention relates to the discovery of a protein that alters chromatin structure and mediates transcriptional repression, leading to novel biological tools and methods.

Career Highlights

Throughout his career, Jianxiang Wang has worked with prominent organizations, including the Department of Health and Human Services in the United States and Juventas Cell Therapy Ltd. His innovative work has positioned him as a key figure in the biotechnology sector.

Collaborations

Wang has collaborated with notable professionals in his field, including Johnson M Liu and Min Wang. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Jianxiang Wang's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical therapies and diagnostics.